Fault Tolerant Strategies for Automated Insulin Delivery Considering the Human Component: Current and Future Perspectives

J Diabetes Sci Technol. 2021 Nov;15(6):1224-1231. doi: 10.1177/19322968211029297. Epub 2021 Jul 21.

Abstract

Automated Insulin Delivery (AID) are systems developed for daily use by people with type 1 diabetes (T1D). To ensure the safety of users, it is essential to consider how the human factor affects the performance and safety of these devices. While there are numerous publications on hardware-related failures of AID systems, there are few studies on the human component of the system. From a control point of view, people with T1D using AID systems are at the same time the plant to be controlled and the plant operator. Therefore, users may induce faults in the controller, sensors, actuators, and the plant itself. Strategies to cope with the human interaction in AID systems are needed for further development of the technology. In this paper, we present an analysis of potential faults introduced by AID users when the system is under normal operation. This is followed by a review of current fault tolerant control (FTC) approaches to identify missing areas of research. The paper concludes with a discussion on future directions for the new generation of FTC AID systems.

Keywords: artificial pancreas; continuous glucose monitoring; fault tolerant control; human-in-the-loop; insulin pump; type 1 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Blood Glucose
  • Humans
  • Hypoglycemic Agents
  • Insulin Infusion Systems
  • Insulin*
  • Pancreas, Artificial*

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin